Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 6.4% in the afternoon session after a major long-term study from ...

The S&P 500 Healthcare sector (XLV) experienced a rise in average short interest during November, moving from 1.97% to 2.12%.

Shares of major COVID-19 vaccine makers, Moderna ($MRNA), BioNTech ($BNTX), and Novavax ($NVAX) fell 6%, 5%, and 4%, ...

Moderna (NASDAQ: MRNA) extended gains for the seventh consecutive trading session, with the stock closing 2.14% higher at $29 ...

Good things could be on the horizon when a stock surpasses the 20-day simple moving average. How should investors react?

Moderna (MRNA) stock has reached day 5 of a consecutive winning streak, with total gains during this time reaching a 13% return. The company’s value has increased by approximately $1.2 billion over ...

Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading today, for the November 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options ...

Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading today, for the December 12th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options ...

The COVID-19 vaccine maker reported quarterly sales of $1.02 billion, topping the expected $886.54 million. Sales declined 45% to $1.9 billion from a year ago, primarily due to a $847 million, or 47%, ...